Search clinical trials for: AMG 386
Total 3461 results
-
AmgenTerminatedSchizophreniaUnited States, France, United Kingdom, Malaysia, Poland, Czech Republic
-
AmgenTerminatedDiabetes MellitusUnited States
-
Seoul National University HospitalMinistry of Food and Drug Safety, KoreaCompletedAnesthesia, General | Neuromuscular BlockadeKorea, Republic of
-
NantCell, Inc.TerminatedSarcoma | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Metastatic Cancer | Solid Tumors | Locally Advanced
-
Jiangsu Kanion Pharmaceutical Co., LtdBeijing Bionovo Medicine Development Co., Ltd.Completed
-
AmgenTerminatedChronic Graft Versus Host Disease cGVHDUnited States, Japan, France, Belgium
-
AmgenCompleted
-
Boehringer IngelheimCompletedMultiple MyelomaGermany, France
-
CytokineticsWithdrawn
-
AmgenCompletedUlcerative ColitisUnited States, Belgium, Canada, Denmark, Italy, Hungary, Germany, Switzerland, Netherlands, Australia, Russian Federation, Austria, France, United Kingdom, Czechia, Greece, Poland, Estonia, Latvia, Norway
-
AmgenCompletedCrohn's DiseaseUnited States, Canada, Denmark, Belgium, Hungary, Switzerland, Netherlands, Austria, Czechia, France, United Kingdom, Germany
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS | Hematology
-
AmgenCompletedIdiopathic Thrombocytopenic Purpura | Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
-
AmgenCompletedThrombocytopenia | Idiopathic Thrombocytopenic Purpura
-
Seoul National University HospitalMinistry of Food and Drug Safety, KoreaCompletedAnesthesia, General | Neuromuscular BlockadeKorea, Republic of
-
Matias VestedNot yet recruitingNeuromuscular BlockadeDenmark
-
CytokineticsWithdrawnChronic Heart Failure With Reduced Ejection Fraction
-
AmgenCompletedChronic Kidney Disease, Secondary HyperparathyroidismBelgium, United States, Germany, Poland, United Kingdom, Lithuania
-
AmgenCompletedLupus Arthritis, Systemic Lupus ErythematosusUnited States, Taiwan, Germany, Denmark, Australia, United Kingdom, Malaysia, France
-
M.D. Anderson Cancer CenterAmgenWithdrawnProstate CancerUnited States
-
AmgenTerminated
-
AmgenCompletedPsoriasisNew Zealand, Australia
-
AmgenActive, not recruitingSmall Cell Lung CancerUnited States, Belgium, Austria, Singapore, Taiwan, Japan
-
AmgenCompletedCarcinoma | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerBelgium, Spain, Australia
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia, Netherlands, Canada, Denmark, Iceland, Japan
-
AmgenCompletedIdiopathic Thrombocytopenic PurpuraItaly, United States, Germany, Czechia, United Kingdom, Australia, Spain, Poland, France
-
MedImmune LLCAmgenCompletedPrimary Sjögren's SyndromeUnited States, Sweden, France, United Kingdom
-
Bausch Health Americas, Inc.Terminated
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasm, Prostate | Neoplasm,ProstaticUnited States
-
Aristotle University Of ThessalonikiCompleted
-
Whanin Pharmaceutical CompanyEnrolling by invitationSchizophreniaKorea, Republic of
-
AmgenRecruitingAtopic DermatitisUnited States, Canada
-
AmgenRecruitingUlcerative ColitisUnited States, Taiwan, Switzerland, Germany, Spain, Turkey, Greece, Japan, Denmark, Korea, Republic of, Austria, Italy, Netherlands, Poland, Romania, Belgium, Argentina, Bulgaria, Czechia, Finland, Hungary, Mexico, Latvia, France, Canada, Slovaki...
-
AmgenCompleted
-
AmgenTerminatedRheumatoid Arthritis RAUnited States, Poland, Germany, Bulgaria, Spain
-
AstraZenecaParexelRecruiting
-
AmgenCompleted
-
AmgenCompletedHealthy Volunteers | Atopic Dermatitis
-
CytokineticsCompletedHealthy VolunteerJapan
-
AmgenMedImmune LLCTerminatedGI AdenocarcinomaGermany, Netherlands
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
AmgenCompletedIdiopathic Thrombocytopenic Purpura
-
AmgenCompletedDetermination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)Myelodysplastic Syndromes | Thrombocytopenia | MDS | Refractory Cytopenias
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom
-
AmgenRecruitingUlcerative ColitisUnited States, Germany, Japan, Denmark, Romania, Argentina, Bulgaria, Hungary, Korea, Republic of, Mexico, Poland, Switzerland, Turkey
-
AmgenUCB PharmaCompletedFracture HealingCanada, Italy, United States, Russian Federation, France, Germany, Hong Kong, Hungary, Australia, Bulgaria, Poland, Romania, Greece, Denmark, Estonia, India, New Zealand, United Kingdom, Latvia, Slovakia, Lithuania, Mexico, Norway